Ann Hanham
Chairman en HTG MOLECULAR DIAGNOSTICS, INC. .
Fortuna: 34 724 $ al 31/03/2024
Perfil
Ann F.
Hanham was the founder of InterMune, Inc. (founded in 1998) and held the title of Vice President-Clinical & Regulatory Affairs from 1998 to 2000.
She is currently the Chairman of HTG Molecular Diagnostics, Inc. (since 2016) and an Independent Director of SCYNEXIS, Inc. (since 2008).
Dr. Hanham has also held former positions as Chairman of Adlyfe, Inc., Medical Director of Celtrix Pharmaceuticals, Inc. (from 1991 to 1995), Director of Acusphere, Inc., Director of Immunicon Corp., Director of Sention, Inc., Director of Aerovance, Inc., Director of BioMimetic Therapeutics, Inc. (in 2006), Director of Waterstone Pharmaceuticals, Inc., Managing Director & General Partner of Burrill LLC (from 2000 to 2013), Director of Biotie Therapies Oy (in 2010), Director of Targacept, Inc. (in 2006), Director of Veritas Medicine, Inc., Independent Director of Endocyte, Inc. (from 2011 to 2018), Senior Director-Oncology Product Development of Otsuka America Pharmaceutical, Inc. (from 1995 to 1998), Director of Logical Therapeutics, Inc., Director of NewBridge Pharmaceuticals FZ LLC, Director of Taiwan Liposome Co., Ltd., Managing Director & Founding Partner of BAR Capital Management LLC (from 2013 to 2016), Senior Manager-Medical Affairs of Becton, Dickinson & Co., and Managing Partner of Bar Capital LLC (from 2013 to 2017).
Dr. Hanham's education includes a doctorate from the University of British Columbia, a graduate degree from Simon Fraser University, and an undergraduate degree from the University of Toronto.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SCYNEXIS, INC.
0.06% | 15/06/2023 | 23 622 ( 0.06% ) | 34 724 $ | 31/03/2024 |
| 01/03/2023 | 40 ( 0.00% ) | 0 $ | 31/03/2024 |
Cargos activos de Ann Hanham
| Empresas | Cargo | Inicio |
|---|---|---|
| SCYNEXIS, INC. | Director/Board Member | 01/12/2008 |
| HTG MOLECULAR DIAGNOSTICS, INC. | Chairman | 18/01/2021 |
Antiguos cargos conocidos de Ann Hanham.
| Empresas | Cargo | Fin |
|---|---|---|
| ENDOCYTE, INC. | Director/Board Member | 01/01/2018 |
| Bar Capital LLC | Corporate Officer/Principal | 01/03/2017 |
BAR Capital Management LLC
 BAR Capital Management LLC Investment ManagersFinance BAR Capital Management LLC is a private equity/venture capital firm founded in 2005 by Roger E. Wyse. The firm is headquartered in Woodside. | Corporate Officer/Principal | 31/12/2016 |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Chief Executive Officer | 01/11/2013 |
Veritas Medicine, Inc.
 Veritas Medicine, Inc. Internet Software/ServicesTechnology Services Veritas Medicine, Inc. operates an online database of clinical trials. It offers patient enrollment solutions to determine eligibility for upcoming clinical trials. The company was founded by Robert Adelman, Joshua Schultz, and Stephen Knight in 1999 and is headquartered in Cambridge, MA. | Director/Board Member | 16/05/2011 |
Formación de Ann Hanham.
| University of British Columbia | Doctorate Degree |
| Simon Fraser University | Graduate Degree |
| University of Toronto | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| BECTON, DICKINSON AND COMPANY | Health Technology |
| ACUSPHERE, INC. | Health Technology |
| HTG MOLECULAR DIAGNOSTICS, INC. | Commercial Services |
| SCYNEXIS, INC. | Health Technology |
| Empresas privadas | 19 |
|---|---|
Celtrix Pharmaceuticals, Inc.
 Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Insmed, Inc., Celtrix Pharmaceuticals, Inc. researches and develops potential therapeutic products. The private company is based in Santa Clara, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Immunicon Corp.
 Immunicon Corp. Medical SpecialtiesHealth Technology Immunicon Corp. develops, manufactures, markets and sells proprietary cell-based diagnostic and research products and services. It provides services to pharmaceutical and biotechnology companies to develop new therapeutic agents, which focuses on cancer disease management. Immunicon's products and technology platforms have application in cancer research and in other fields of medicine, such as cardiovascular and infectious disease. The company was founded in 1983 and is headquartered in Huntingdon Valley, PA. | Health Technology |
Sention, Inc.
 Sention, Inc. Pharmaceuticals: MajorHealth Technology Sention, Inc. manufactures pharmaceutical products. The company focuses on the discovery and development of drugs to treat memory impairment and other central nervous disorders. The company was founded in 1999 and is headquartered in Providence, RI | Health Technology |
Aerovance, Inc.
 Aerovance, Inc. Medical DistributorsDistribution Services Aerovance, Inc. develops drugs for respiratory and inflammatory diseases. The company was founded by Jeffrey Howard Tepper and Wolf-Dieter Busse in July 29, 2004 and is headquartered in Berkeley, CA. | Distribution Services |
BioMimetic Therapeutics, Inc.
 BioMimetic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioMimetic Therapeutics, Inc. developed and sells protein therapeutics for tissue and organ regeneration. The company was founded by Samuel E. Lynch and David M. Renzi on April 14, 1999 and was headquartered in Franklin, TN. | Health Technology |
Adlyfe, Inc.
 Adlyfe, Inc. Medical DistributorsDistribution Services Adlyfe, Inc. is a privately held early stage biotechnology company that utilizes novel and proprietary peptide technology to develop solutions for early detection of protein misfolding diseases. It offers Pronucleon, a platform technology using custom-synthesized peptides that allow signal amplification to map the surface of rare proteins. The firm's technology detects the sequence and the conformation of amyloid proteins, to create sensitive and specific detection methods that allow early stage diagnosis and disease progression monitoring. Adlyfe was founded in 2003 by Richard O. Cliff and is headquartered in Rockville, MD. | Distribution Services |
Waterstone Pharmaceuticals, Inc.
 Waterstone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Waterstone Pharmaceuticals, Inc. engages in the provision of discovery, development, and commercialization of innovative drugs for the treatment of liver and gastrointestinal diseases. The company was founded by Faming Zhang in 2008 and is headquartered in Carmel, IN. | Health Technology |
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Finance |
Biotie Therapies Oy
 Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Biotie Therapies Oy engages in the research, development, and commercialization of pharmaceutical products. The company was founded by Markku Tapani Jalkanen and Sirpa Tuulikki Jalkanen in June 1992 and is headquartered in Helsinki, Finland. | Health Technology |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Targacept, Inc. is a biopharmaceutical company, which is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting Neuronal Nicotinic Receptors, or NNRs. NNRs are found on nerve cells throughout the human nervous system and serve as key regulators of nervous system activity. Targacept was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello on March 7, 1997 and is headquartered in Winston-Salem, NC. | Health Technology |
Veritas Medicine, Inc.
Veritas Medicine, Inc. Internet Software/ServicesTechnology Services Veritas Medicine, Inc. operates an online database of clinical trials. It offers patient enrollment solutions to determine eligibility for upcoming clinical trials. The company was founded by Robert Adelman, Joshua Schultz, and Stephen Knight in 1999 and is headquartered in Cambridge, MA. | Technology Services |
Endocyte, Inc.
 Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Health Technology |
Logical Therapeutics, Inc.
 Logical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Logical Therapeutics, Inc. develops products that treat diseases associated with inflammation. It provides a platform of bio-activated prodrugs for the chronic treatment of arthritis. Its bio-activated NSAID prodrugs are chemical entities that are designed to reduce the incidence of GI ulcers and improve GI tolerability in patients who require chronic NSAID treatment. The company was founded by Carolyn E. Green in 2005 and is headquartered in Waltham, MA. | Health Technology |
NewBridge Pharmaceuticals FZ LLC
 NewBridge Pharmaceuticals FZ LLC Pharmaceuticals: MajorHealth Technology NewBridge Pharmaceuticals FZ LLC engages in the manufacture and distribution of pharmaceutical products, therapeutics and medical devices. The company was founded by G. Garrett Vygantas in 2007 and is headquartered in Dubai, United Arab Emirates. | Health Technology |
Taiwan Liposome Co., Ltd.
 Taiwan Liposome Co., Ltd. Pharmaceuticals: MajorHealth Technology Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered in Taipei, Taiwan. | Health Technology |
BAR Capital Management LLC
BAR Capital Management LLC Investment ManagersFinance BAR Capital Management LLC is a private equity/venture capital firm founded in 2005 by Roger E. Wyse. The firm is headquartered in Woodside. | Finance |
| Bar Capital LLC |
- Bolsa de valores
- Insiders
- Ann Hanham
